1. Home
  2. RGEN vs AFRM Comparison

RGEN vs AFRM Comparison

Compare RGEN & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • AFRM
  • Stock Information
  • Founded
  • RGEN 1981
  • AFRM 2012
  • Country
  • RGEN United States
  • AFRM United States
  • Employees
  • RGEN N/A
  • AFRM N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • AFRM Business Services
  • Sector
  • RGEN Health Care
  • AFRM Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • AFRM Nasdaq
  • Market Cap
  • RGEN 8.2B
  • AFRM 12.0B
  • IPO Year
  • RGEN N/A
  • AFRM 2021
  • Fundamental
  • Price
  • RGEN $138.26
  • AFRM $44.57
  • Analyst Decision
  • RGEN Buy
  • AFRM Hold
  • Analyst Count
  • RGEN 10
  • AFRM 19
  • Target Price
  • RGEN $188.38
  • AFRM $36.83
  • AVG Volume (30 Days)
  • RGEN 772.8K
  • AFRM 13.3M
  • Earning Date
  • RGEN 10-29-2024
  • AFRM 11-06-2024
  • Dividend Yield
  • RGEN N/A
  • AFRM N/A
  • EPS Growth
  • RGEN N/A
  • AFRM N/A
  • EPS
  • RGEN N/A
  • AFRM N/A
  • Revenue
  • RGEN $602,354,000.00
  • AFRM $2,322,999,000.00
  • Revenue This Year
  • RGEN $0.08
  • AFRM $31.21
  • Revenue Next Year
  • RGEN $12.97
  • AFRM $20.31
  • P/E Ratio
  • RGEN N/A
  • AFRM N/A
  • Revenue Growth
  • RGEN N/A
  • AFRM 46.29
  • 52 Week Low
  • RGEN $110.45
  • AFRM $15.97
  • 52 Week High
  • RGEN $211.13
  • AFRM $52.48
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 38.85
  • AFRM 71.18
  • Support Level
  • RGEN $135.88
  • AFRM $35.72
  • Resistance Level
  • RGEN $142.86
  • AFRM $45.08
  • Average True Range (ATR)
  • RGEN 5.04
  • AFRM 2.91
  • MACD
  • RGEN -1.18
  • AFRM 0.39
  • Stochastic Oscillator
  • RGEN 8.54
  • AFRM 88.89

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About AFRM Affirm Holdings Inc.

Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.

Share on Social Networks: